naltrexone has been researched along with Left Ventricular Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehe, L; Habazettl, H; Mousa, SA; Nordine, M; Schäfer, M; Schluchter, H; Shakibaei, M; Shaqura, M; Treskatsch, S; von Kwiatkowski, P | 1 |
| Barzakh, EI; Lasukova, TV; Lishmanov, YB; Maslov, LN; Oeltgen, PR; Rice, KK | 1 |
2 other study(ies) available for naltrexone and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Chronic Naltrexone Therapy Is Associated with Improved Cardiac Function in Volume Overloaded Rats.
Topics: Angiotensin II; Animals; Disease Models, Animal; Heart Function Tests; Myocytes, Cardiac; Naltrexone; Narcotic Antagonists; Nerve Tissue Proteins; Rats; Rats, Wistar; Receptors, Opioid; Treatment Outcome; Ventricular Dysfunction, Left; Water Intoxication | 2021 |
Negative inotropic and chronotropic effects of delta-opioid receptor antagonists are mediated via non-opioid receptors.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Ligands; Myocardial Contraction; Myocardium; Naloxone; Naltrexone; Perfusion; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Ventricular Dysfunction, Left | 2006 |